Integral Derivatives’s Comerica CMA Stock Holding History

Integral Derivatives’s Portfolio CMA Stock Details CMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-8,900	Closed	-$423K	–	1336
2013 Q4	$423K	Buy	+8,900	New	+$391K	0.01%	1104

Other funds holding CMA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

Integral Derivatives's CMA Position: Q2 2017 in Review

Integral Derivatives sold out of Comerica (CMA) in Q2 2017, closing a stake of 8,400 shares — an estimated $576K sold.

Integral Derivatives first reported a position in CMA in Q4 2013 and held it in 3 quarters. The position peaked at $694K in Q4 2013. 512 funds tracked by Wall St. Rank hold CMA as of Q2 2017.

Integral Derivatives reported no remaining Comerica position as of Q2 2017 after selling out during the quarter.
Integral Derivatives sold 8,400 Comerica shares in Q2 2017, an estimated $576K.
Integral Derivatives first reported a position in Comerica in Q4 2013 and held it in 3 quarters.
Integral Derivatives's Comerica position peaked at $694K in Q4 2013.
512 funds tracked by Wall St. Rank held Comerica as of Q2 2017.

Based on Integral Derivatives's 13F filing for Q2 2017, filed 14 Aug 2017.